McKesson expects 2027 profit slightly above estimates on drug distribution strength

McKesson forecast 2027 profit slightly above Wall Street expectations after topping first-quarter profit estimates. The outlook is supported by strength in its oncology and specialty drug businesses, suggesting continued momentum in core healthcare distribution operations. The update is positive but incremental rather than transformative.

Analysis

McKesson forecast 2027 profit slightly above Wall Street expectations after topping first-quarter profit estimates. The outlook is supported by strength in its oncology and specialty drug businesses, suggesting continued momentum in core healthcare distribution operations. The update is positive but incremental rather than transformative.